Julia Brain
About Julia Brain
Julia Brain is the Vice President, World Wide Medical Hematology-Lymphoma Lead at Bristol Myers Squibb, with extensive experience in oncology and hematology, having previously held leadership roles at Regeneron, Ipsen, and Merck.
Current Position at Bristol Myers Squibb
Julia Brain is the Vice President, World Wide Medical Hematology-Lymphoma Lead at Bristol Myers Squibb. She operates out of the New York City Metropolitan Area and manages global medical strategies focused on hematology and lymphoma. Her role involves leading a team of medical professionals and overseeing the clinical development and implementation of new oncology treatments.
Previous Roles in Pharmaceuticals
Before joining Bristol Myers Squibb, Julia Brain served as the Executive Director of Global Medical Affairs at Regeneron Pharmaceuticals from 2020 to 2021. Prior to that, she was the Head of Global Medical Affairs at Ipsen from 2019 to 2020. She also held multiple roles at Merck, including Executive Director of Global Medical Affairs from 2012 to 2018 and Director of Medical Affairs from 2014 to 2016. Earlier in her career, she worked at Seattle Genetics and Inspire, focusing on medical science liaison roles.
Educational Background
Julia Brain completed her Fellowship in Hematology/Oncology at Harvard Medical School from 2001 to 2004. She earned her Doctor of Philosophy (PhD) in Experimental Medicine from McGill University, where she studied from 1995 to 2001. Her education has provided a solid foundation for her extensive work in medical affairs, particularly in oncology and hematology.
Role in PD-1 Inhibitors Development
Julia Brain played a pivotal role in the clinical development and strategic implementation of PD-1 inhibitors, particularly KEYTRUDA. Her work has significantly contributed to the drug's position as a cornerstone treatment in cancer immunotherapy. She has been instrumental in shaping the clinical strategy for KEYTRUDA, leading to its widespread adoption in oncology protocols.
Expertise in Clinical Trials and Drug Approvals
Julia Brain has extensive experience in presenting clinical trial data and securing drug approvals from regulatory agencies across multiple countries. She has chaired numerous international advisory boards aimed at optimizing clinical trial designs and global medical strategies for oncology drugs. Her background in pharmacology and toxicology has been integral to designing safer and more effective cancer treatments.